Trial Profile

Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dalteparin sodium (Primary) ; Enoxaparin sodium; Heparin; Nadroparin calcium; Phenprocoumon; Warfarin
Indications Deep vein thrombosis; Venous thromboembolism; Venous thrombosis
Focus Adverse reactions; Therapeutic Use
Acronyms Kids-DOTT

Most Recent Events

12 Dec 2023 Results of secondary analysis (n=532) presented at the 65th American Society of Hematology Annual Meeting and Exposition
01 Mar 2022 Status changed from active, no longer recruiting to completed.
28 Jan 2022 Planned End Date changed from 31 Jan 2022 to 28 Feb 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com